Purchase Order 36C24225P0025
Award Date
10/22/24
Potential Completion Date
11/30/24
Potential Value
$75K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Optum Pharmacy 801, Inc.
Ultimate Awardee
Unitedhealth Group Incorporated
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Orange, NJ 07018, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $5,773,549.83, is for the provision of pharmacy compounding services, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications. The contract has a period of performance through September 30, 2024. Optum Pharmacy 601 has received multiple awards from various Veterans...
The federal contract award with ID 36C24221A0010|36C24224N0317 was issued by the Veterans Integrated Service Network 2 (VISN 2), a component of the U.S. Department of Veterans Affairs (VA), to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The $21,490.22 Firm Fixed Price contract is a Blanket Purchase Agreement (BPA) call for chemotherapy compound drug hood services, with a period of performance through November 19, 2024. Optum Pharmacy 601 is an established government...
This federal contract award is for CHEMO COMPOUNDING SERVICES with a period of performance through September 30, 2025. The $674,796.03 firm fixed-price delivery order was awarded on December 11, 2023 to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The award is not set-aside and represents a specialized pharmaceutical compounding services contract focused on providing customized...
This federal contract award, valued at $20,000.00, is for Pharmacy Compound Drugs Option Year 4 Order to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 2 (VISN 2), to provide pharmacy compounding services, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications. The contract has a firm fixed-price pricing...
This is a $82,038.47 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group that specializes in providing pharmacy services to the VA and Veterans Health Administration (VHA). The award is for emergency procurement of compound prescriptions, with an ultimate completion date of February 4, 2020. The contract is not set-aside. Optum Pharmacy 601 holds several VA/VHA indefinite delivery contracts and...
This is a $2,500,000.00 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the Baltimore VA Medical Center. The contract has an ultimate completion date of June 30, 2030 and was awarded on July 28, 2025. The original solicitation (36C24525Q0460) was for full and open competition, with no set-aside designation. Optum...
This is a definitive, firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $4,519,085.96, is for sterile hazardous compounding services to be provided to the VA's Veterans Integrated Service Network (VISN) 16, which covers facilities in Arkansas. The contract has a period of performance through December 25, 2024 and was not set aside for any particular business type. Optum...
This is a $55,205.54 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the VA Baltimore Medical Center. The contract has a performance period through June 30, 2025. This requirement was competed on a full and open basis, without any set-aside designations. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, has...
This federal contract award is for hazardous pharmaceutical compounding services provided by Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $350,610.57, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16) on a firm fixed-price basis with a completion date of September 30, 2025. Optum Pharmacy 801, Inc. has a history of securing multiple...
This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The $251,754.51 firm fixed price purchase order is for chemo compounding services to support veterans healthcare programs. Optum Pharmacy 601 provides specialized pharmacy services from its location in Brandon, Florida, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV...